Funding Rounds
Sphingotec

Sphingotec Series C (2024, $5M)

Sphingotec

Biomarkers developer for diagnosis, prediction and monitoring of acute medical conditions.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $5.47M

Raised Date: 2024-08-01

Investors